Segmented negative-strand RNA viruses, like seasonal and pandemic influenza viruses and pathogenic bunyaviruses, pose continuous medical and economic threat for the society, urging the need for the design of novel antiviral compounds. RNA-dependent RNA polymerases are pivotal viral proteins responsible for transcription, replication, as well as specific interactions with the viral subgenomic RNAs. Primary objective of this project is to design and test a novel class of small, RNA-based molecules, inhibitory against viral polymerases, that could be further developed into efficient antiviral drugs.
Key responsibilities of the successful candidate will be to: (1) participate in designing RNA-based small inhibitory molecules; (2) set up expression and purification of the trimeric influenza virus polymerases; (3) perform various RNA-polymerase assays; (4) determine high resolution RNA-polymerase cryo-EM structures. We particularly encourage candidates with a strong interest in molecular research with a direct therapeutic relevance. Successful candidate will contribute to the conceptual development of the project, and will be involved in preparation of both scientific publications and patent applications.